XORTX Operating Income from 2010 to 2026
| XRTX Stock | 0.49 0.02 3.92% |
Operating Income | First Reported 2020-12-31 | Previous Quarter -889.9 K | Current Value -716.2 K | Quarterly Volatility 1 M |
Check XORTX Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among XORTX Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Net Interest Income of 147.2 K or Selling General Administrative of 1.9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.96. XORTX financial statements analysis is a perfect complement when working with XORTX Therapeutics Valuation or Volatility modules.
XORTX | Operating Income |
The evolution of Operating Income for XORTX Therapeutics provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how XORTX Therapeutics compares to historical norms and industry peers.
Latest XORTX Therapeutics' Operating Income Growth Pattern
Below is the plot of the Operating Income of XORTX Therapeutics over the last few years. Operating Income is the amount of profit realized from XORTX Therapeutics operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of XORTX Therapeutics is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. XORTX Therapeutics' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in XORTX Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
XORTX Operating Income Regression Statistics
| Arithmetic Mean | (2,562,107) | |
| Coefficient Of Variation | (95.33) | |
| Mean Deviation | 1,870,793 | |
| Median | (1,157,219) | |
| Standard Deviation | 2,442,478 | |
| Sample Variance | 6T | |
| Range | 9.3M | |
| R-Value | (0.63) | |
| Mean Square Error | 3.9T | |
| R-Squared | 0.39 | |
| Significance | 0.01 | |
| Slope | (303,736) | |
| Total Sum of Squares | 95.5T |
XORTX Operating Income History
About XORTX Therapeutics Financial Statements
XORTX Therapeutics investors use historical fundamental indicators, such as XORTX Therapeutics' Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in XORTX Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Income | -3.7 M | -3.9 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for XORTX Stock Analysis
When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.